共同药业
(300966)
| 流通市值：20.44亿 | | | 总市值：30.73亿 |
| 流通股本：7666.67万 | | | 总股本：1.15亿 |
| 报告期 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 75,480,928.25 | 85,845,945.61 | 94,657,088.95 | 133,827,483.67 |
| 结算备付金 | - | - | - | 0 |
| 拆出资金 | - | - | - | 0 |
| 交易性金融资产 | 1,010.8 | 1,010.76 | 1,010.73 | 1,010.7 |
| 衍生金融资产 | 0 | 0 | - | 0 |
| 应收票据及应收账款 | 201,257,635.6 | 177,895,070.11 | 187,383,225.81 | 257,875,528.31 |
| 其中：应收票据 | 12,246,940.44 | 18,545,191.89 | 18,806,936.84 | 18,481,550.85 |
| 应收账款 | 189,010,695.16 | 159,349,878.22 | 168,576,288.97 | 239,393,977.46 |
| 应收款项融资 | 26,841,206.07 | 11,207,056.13 | 9,517,056.35 | 4,827,537.43 |
| 预付款项 | 21,889,747.39 | 7,016,148.45 | 13,522,837.68 | 4,653,629.39 |
| 应收保费 | - | - | - | 0 |
| 应收分保账款 | - | - | - | 0 |
| 应收分保合同准备金 | - | - | - | 0 |
| 其他应收款合计 | 4,256,800 | 3,296,875.94 | 2,587,664.75 | 2,427,007.97 |
| 其中:应收利息 | 0 | 0 | - | 0 |
| 应收股利 | 0 | 0 | - | 0 |
| 买入返售金融资产 | - | - | - | 0 |
| 存货 | 486,543,112.55 | 473,756,771.1 | 460,119,764.59 | 440,055,287.92 |
| 合同资产 | 0 | 0 | - | 0 |
| 一年内到期的非流动资产 | 0 | 0 | - | 0 |
| 其他流动资产 | 8,900,069.88 | 11,268,530.09 | 11,897,799.31 | 10,913,227.35 |
| 流动资产合计 | 825,170,510.54 | 770,287,408.19 | 779,686,448.17 | 854,580,712.74 |
| 非流动资产: | | | | |
| 发放委托贷款及垫款 | - | - | - | 0 |
| 债权投资 | 0 | 0 | - | 0 |
| 其他债权投资 | 0 | 0 | - | 0 |
| 长期应收款 | 0 | 0 | - | 0 |
| 长期股权投资 | 47,060,821.79 | 48,294,720.92 | 48,300,809.91 | 48,332,445.18 |
| 其他权益工具投资 | 0 | 0 | - | 0 |
| 其他非流动金融资产 | 0 | 0 | - | 0 |
| 投资性房地产 | 17,227,003.79 | 17,384,513.6 | 17,542,023.41 | 17,699,533.22 |
| 固定资产 | 1,544,179,137.29 | 1,549,239,328.73 | 1,616,726,694.37 | 1,136,696,153.48 |
| 在建工程 | 324,109,716.72 | 333,586,196.15 | 273,908,908.03 | 761,804,636.83 |
| 生产性生物资产 | 0 | 0 | - | 0 |
| 油气资产 | 0 | 0 | - | 0 |
| 使用权资产 | 0 | 14,175.28 | 28,350.61 | 42,525.94 |
| 无形资产 | 53,483,686.7 | 53,787,523.55 | 49,045,247.12 | 49,323,853.4 |
| 开发支出 | 0 | 0 | - | 0 |
| 商誉 | 0 | 0 | - | 0 |
| 长期待摊费用 | 5,734,405.9 | 6,561,599.11 | 7,143,618.63 | 7,970,503.32 |
| 递延所得税资产 | 65,602,876.16 | 62,770,786.4 | 55,183,260.26 | 46,903,061.78 |
| 其他非流动资产 | 13,553,527.98 | 8,732,007.28 | 9,197,384.89 | 11,821,104.14 |
| 非流动资产合计 | 2,070,951,176.33 | 2,080,370,851.02 | 2,077,076,297.23 | 2,080,593,817.29 |
| 资产总计 | 2,896,121,686.87 | 2,850,658,259.21 | 2,856,762,745.4 | 2,935,174,530.03 |
| 流动负债: | | | | |
| 短期借款 | 220,762,402.77 | 229,753,280.41 | 213,246,602.09 | 222,153,151.38 |
| 向中央银行借款 | - | - | - | 0 |
| 吸收存款及同业存放 | - | - | - | 0 |
| 拆入资金 | - | - | - | 0 |
| 交易性金融负债 | 0 | 0 | - | 0 |
| 衍生金融负债 | 0 | 0 | - | 0 |
| 应付票据及应付账款 | 491,591,017.74 | 461,258,451.31 | 459,801,803.68 | 524,545,403.54 |
| 其中：应付票据 | 69,192,086 | 37,000,000 | 35,000,000 | 77,066,120 |
| 应付账款 | 422,398,931.74 | 424,258,451.31 | 424,801,803.68 | 447,479,283.54 |
| 预收款项 | 472,660.46 | 47,266.1 | 189,064.25 | 329,845.26 |
| 合同负债 | 4,295,787.49 | 6,593,536.43 | 222,310.03 | 605,760.17 |
| 卖出回购金融资产款 | - | - | - | 0 |
| 应付手续费及佣金 | - | - | - | 0 |
| 应付职工薪酬 | 5,648,987.6 | 9,640,399.17 | 6,378,941.65 | 5,551,980.57 |
| 应交税费 | 973,717.3 | 427,671.32 | 893,129.56 | 354,686.32 |
| 其他应付款合计 | 1,442,962.92 | 1,356,502.77 | 1,060,050.05 | 988,271.02 |
| 其中:应付利息 | 0 | 0 | - | 0 |
| 应付股利 | 0 | 0 | - | 0 |
| 应付分保账款 | - | - | - | 0 |
| 保险合同准备金 | - | - | - | 0 |
| 代理买卖证券款 | - | - | - | 0 |
| 代理承销证券款 | - | - | - | 0 |
| 一年内到期的非流动负债 | 98,377,945.61 | 95,345,131.59 | 63,020,076.12 | 39,152,910.81 |
| 其他流动负债 | 9,646,266.11 | 17,654,540.47 | 18,028,779.85 | 28,062,560.21 |
| 流动负债合计 | 833,211,748 | 822,076,779.57 | 762,840,757.28 | 821,744,569.28 |
| 非流动负债: | | | | |
| 长期借款 | 639,955,505.8 | 621,305,505.8 | 645,810,434.51 | 625,098,254.73 |
| 应付债券 | 358,833,932.45 | 352,850,540.3 | 346,698,594.49 | 340,325,879.53 |
| 优先股 | 0 | 0 | - | 0 |
| 永续债 | 0 | 0 | - | 0 |
| 租赁负债 | 0 | 0 | - | 0 |
| 长期应付款 | 0 | 0 | - | 0 |
| 长期应付职工薪酬 | 0 | 0 | - | 0 |
| 预计负债 | 24,941.97 | 24,941.97 | - | 4,333,250.51 |
| 递延收益 | 152,382,074.44 | 144,061,058.65 | 142,763,362.78 | 146,177,677.55 |
| 递延所得税负债 | 1,104,828.23 | 982,487.04 | 744,076.15 | 173,506.38 |
| 其他非流动负债 | 0 | 0 | - | 0 |
| 非流动负债合计 | 1,152,301,282.89 | 1,119,224,533.76 | 1,136,016,467.93 | 1,116,108,568.7 |
| 负债合计 | 1,985,513,030.89 | 1,941,301,313.33 | 1,898,857,225.21 | 1,937,853,137.98 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 115,281,113 | 115,281,113 | 115,281,077 | 115,279,416 |
| 其他权益工具 | 96,478,492.63 | 96,478,492.63 | 96,478,233.81 | 96,489,947.36 |
| 资本公积 | 409,152,067.46 | 409,022,940.42 | 411,074,051.09 | 410,963,755.31 |
| 减:库存股 | 21,972,301.43 | 21,972,301.43 | 19,770,502.95 | 3,030,264.52 |
| 其他综合收益 | 0 | 0 | - | 0 |
| 专项储备 | 0 | 0 | - | 0 |
| 盈余公积 | 9,953,911.25 | 9,953,911.25 | 9,953,911.25 | 9,953,911.25 |
| 一般风险准备 | - | - | - | 0 |
| 未分配利润 | 220,654,107.38 | 217,455,575.7 | 258,379,818.62 | 279,662,169.68 |
| 归属于母公司股东权益合计 | 829,547,390.29 | 826,219,731.57 | 871,396,588.82 | 909,318,935.08 |
| 少数股东权益 | 81,061,265.69 | 83,137,214.31 | 86,508,931.37 | 88,002,456.97 |
| 股东权益合计 | 910,608,655.98 | 909,356,945.88 | 957,905,520.19 | 997,321,392.05 |
| 负债和股东权益合计 | 2,896,121,686.87 | 2,850,658,259.21 | 2,856,762,745.4 | 2,935,174,530.03 |
| 公告日期 | 2026-04-29 | 2026-04-29 | 2025-10-28 | 2025-08-29 |
| 审计意见(境内) | | 标准无保留意见 | | |